DIABETES CARE DEVICES

Diabetes Care Device User Experience Satisfaction & Brand Retention Survey

Diabetes patients and caregivers evaluate, compare, and choose glucose monitoring and insulin delivery devices on accuracy, ease of use, and cost, so you can sharpen retention positioning, fix acquisition messaging, and benchmark switching triggers by device segment.

Pan-India Sample
Diabetes Patients & Caregivers (Active Device Users)
15-20 min
Talk to a Survey Consultant
Switching triggers & drop-offsIdentify the exact usage stage where device dissatisfaction converts to brand exit.
Loyalty drivers & segment rankRank retention signals across patient segments, device categories, and prescription channels.
TRUSTED BY LEADING BRANDS
Brand 0Brand 1Brand 2Brand 3Brand 4Brand 5Brand 6Brand 7Brand 8Brand 9Brand 10Brand 11Brand 12Brand 13Brand 14Brand 15Brand 16Brand 17Brand 18Brand 19Brand 20Brand 21Brand 22Brand 23Brand 24Brand 25Brand 26Brand 27Brand 28Brand 29Brand 30Brand 31

CONTEXT & RELEVANCE

Why run this survey now

Most diabetes care device brands don't lose users purely on clinical performance. They lose them due to sensor discomfort, connectivity failures, calibration friction, reimbursement confusion, and inadequate onboarding support, none of which fully show up in post-market surveillance reports or pharmacy sales data.

If you are...

  • CGM or BGM brand portfolio lead

  • Insulin delivery device product head

  • Device commercial or pricing lead

  • Patient retention or CRM lead

  • Diabetes care strategy director

You're likely facing...

  • Brand switch at prescription renewal

  • Sensor wear drop-off: week 2-4

  • CGM = accurate/complex perception

  • Reimbursement friction vs. OOP cost

  • Device loyalty vs. app ecosystem gaps

This will help answer...

  • Retention drivers beyond device accuracy

  • Drop-off stage in usage journey

  • Segment preference by therapy type

  • Pricing tolerance vs. reimbursement gap

  • Switch triggers at renewal window

RESEARCH THEMES

What This Survey Investigates

Eight interconnected research themes that map the complete diabetes care device journey from first prescription to long-term brand retention.

TENETS 01

Device Discovery

  • First device recommended, self-selected
  • HCP influence vs. pharmacy pull
TENETS 02

Device Preference

  • BGM vs. CGM adoption triggers
  • Feature priorities at point of selection
TENETS 03

Onboarding & Setup

  • First-use friction, calibration difficulty
  • Training source, setup support received
TENETS 04

Daily Use Friction

  • Wear comfort, skin irritation rates
  • Alert fatigue, reading frequency drop-off
TENETS 05

Pricing & Affordability

  • Out-of-pocket spend, insurance coverage gaps
  • Consumable cost tolerance, refill behaviour
TENETS 06

App & Connectivity

  • Companion app engagement, sync reliability
  • Data sharing with HCP, care team
TENETS 07

Brand Satisfaction

  • Accuracy trust, brand confidence score
  • After-sales support, warranty experience
TENETS 08

Retention & Switching

  • Brand switch triggers, loyalty barriers
  • Competitive trial intent, upgrade readiness
Request a scope validation call

SAMPLING STRATEGY

Tell us about your ideal sample

Help us understand your target respondent profile. Select what applies, we'll design the optimal sample plan based on your inputs.

Sample size
How many respondents do you need?
Not Selected
Target audience
Who should we survey?
Not Selected
Region
Which regions should we cover?
Not Selected
Segments
How should we slice the data?
Not Selected
Discuss sample plan

METHODOLOGY

Survey approach

For the Diabetes Care Device User Experience Satisfaction & Brand Retention Survey, we recommend a quant-first design with flexible data-collection modes to balance reach, depth, and verification across patient, caregiver, and clinician segments.

PRIMARY
Online web surveySelf-administered survey shared via email / panels to capture structured responses at scale.
Best for
1
Measuring device satisfaction scores by condition severity.
2
Ranking brand retention drivers across device categories.
3
Comparing segments by device type, age, and geography.
Deliverables
Satisfaction driver ranking
Brand retention matrix
Segment gap report
OPTIONAL
CATI (phone survey)Interviewer-led telephone interviews to reach owners who are harder to get online.
Best for
1
Older patients with low digital device comfort.
2
Reaching Tier 2 and Tier 3 city users.
Deliverables
Offline user coverage
Call-log diagnostics
SELECTIVE
Face-to-faceOn-ground surveys or interviews in key industrial clusters or high-value cohorts.
Best for
1
Insulin pump and CGM users needing device demonstration context.
2
High-frequency users in specialist diabetes care centres.
Deliverables
Clinic-level insights
Device journey maps
OPTIONAL
FGDs
Deliverables
Themes and quotes
Concept feedback
OPTIONAL
Mixed surveysAny 4-mode combo Online + CATI + F2F + FGDs to maximise reach and representation. Mode-specific quotas and weighting for clean comparisons.
Deliverables
Unified dataset
Mode-adjusted analytics
Our Recommendation
Start with: Online web survey as the core quant layer, targeting digitally active patients and caregivers managing Type 1 and Type 2 diabetes across glucometer, CGM, and insulin delivery device segments.
Consider adding: CATI for older or low-digital patient cohorts in Tier 2 and Tier 3 markets, and a focused FGD layer to isolate brand switching triggers and pressure-test retention messaging before commercial rollout.
Confirm approach
Request timeline

EXECUTION PROCESS

How we execute

A proven 9-step process from scoping to delivery, designed to ensure quality, speed, and actionable insights.

Define the decision frame

Confirm objectives, target cohorts, geographies, and reporting cuts

Step 01

Define the decision frame

Design the instrument

Build workstream modules mapped to outputs (drivers, friction, pricing, retention, trust)

Step 02

Design the instrument

Lock the questionnaire

Review wording, sequencing, LOI, and competitive context; approve final version

Step 03

Lock the questionnaire

Pilot and calibrate

Test comprehension and ease quality; refine quotas and remove friction where needed

Step 04

Pilot and calibrate

Run fieldwork

Execute collection with active quota management and feasibility controls

Step 05

Run fieldwork

Assure quality

Dedupe, attention checks, speed/consistency rules, removals with audit trail

Step 06

Assure quality

Prepare the dataset

Clean data and deliver codebook/variable definitions

Step 07

Prepare the dataset

Analyse and synthesise

Driver ranking, leakage diagnostics, pricing bands, segment insights

Step 08

Analyse and synthesise

Deliver and align

Executive deck (optional dashboard) and leadership readout with recommendations

Step 09

Deliver and align

COMMERCIAL TERMS

Request a Commercial Proposal

Pricing depends on cohort, geography, sample size, approach, LOI, and deliverables. Configure below for an indicative estimate.

Select Sample Size

100

Geography

  • India
  • APAC (Singapore, Vietnam, Philippines, Indonesia, Australia, NZ, Japan, Thailand)
  • Middle East (UAE, KSA, Qatar, Bahrain, Oman, Kuwait)
  • North America (US, Canada)
  • Europe
  • Africa (South Africa, Kenya, Nigeria, Egypt, Algeria)
  • LATAM (Brazil, Mexico)

Select Mode of Survey

  • Online
  • CATI
  • Online FGD (5 people per FGD)
  • F2F

Length of the Interview

  • Select
  • 0-15
  • 16-20
  • 21-30
  • 31-45
  • 46-60
  • Custom
Indicative Estimate
  • Indian Rupee (INR)
  • United Arab Emirates Dirham (AED)
  • Afghan Afghani (AFN)
  • Albanian Lek (ALL)
  • Armenian Dram (AMD)
  • Netherlands Antillean Guilder (ANG)
  • Angolan Kwanza (AOA)
  • Argentine Peso (ARS)
  • Australian Dollar (AUD)
  • Aruban Florin (AWG)
  • Azerbaijani Manat (AZN)
  • Bosnia-Herzegovina Convertible Mark (BAM)
  • Barbadian Dollar (BBD)
  • Bangladeshi Taka (BDT)
  • Bulgarian Lev (BGN)
  • Bahraini Dinar (BHD)
  • Burundian Franc (BIF)
  • Bermudian Dollar (BMD)
  • Brunei Dollar (BND)
  • Bolivian Boliviano (BOB)
  • Brazilian Real (BRL)
  • Bahamian Dollar (BSD)
  • Bhutanese Ngultrum (BTN)
  • Botswana Pula (BWP)
  • Belarusian Ruble (BYN)
  • Belize Dollar (BZD)
  • Canadian Dollar (CAD)
  • Congolese Franc (CDF)
  • Swiss Franc (CHF)
  • Chilean Peso (CLP)
  • Chinese Yuan (CNY)
  • Colombian Peso (COP)
  • Costa Rican Colón (CRC)
  • Cuban Peso (CUP)
  • Cape Verdean Escudo (CVE)
  • Czech Koruna (CZK)
  • Djiboutian Franc (DJF)
  • Danish Krone (DKK)
  • Dominican Peso (DOP)
  • Algerian Dinar (DZD)
  • Egyptian Pound (EGP)
  • Eritrean Nakfa (ERN)
  • Ethiopian Birr (ETB)
  • Euro (EUR)
  • Fijian Dollar (FJD)
  • Falkland Islands Pound (FKP)
  • British Pound (GBP)
  • Georgian Lari (GEL)
  • Ghanaian Cedi (GHS)
  • Gibraltar Pound (GIP)
  • Gambian Dalasi (GMD)
  • Guinean Franc (GNF)
  • Guatemalan Quetzal (GTQ)
  • Guyanese Dollar (GYD)
  • Hong Kong Dollar (HKD)
  • Honduran Lempira (HNL)
  • Croatian Kuna (HRK)
  • Haitian Gourde (HTG)
  • Hungarian Forint (HUF)
  • Indonesian Rupiah (IDR)
  • Israeli New Shekel (ILS)
  • Iraqi Dinar (IQD)
  • Iranian Rial (IRR)
  • Icelandic Króna (ISK)
  • Jamaican Dollar (JMD)
  • Jordanian Dinar (JOD)
  • Japanese Yen (JPY)
  • Kenyan Shilling (KES)
  • Kyrgyzstani Som (KGS)
  • Cambodian Riel (KHR)
  • Comorian Franc (KMF)
  • South Korean Won (KRW)
  • Kuwaiti Dinar (KWD)
  • Cayman Islands Dollar (KYD)
  • Kazakhstani Tenge (KZT)
  • Lao Kip (LAK)
  • Lebanese Pound (LBP)
  • Sri Lankan Rupee (LKR)
  • Liberian Dollar (LRD)
  • Lesotho Loti (LSL)
  • Libyan Dinar (LYD)
  • Moroccan Dirham (MAD)
  • Moldovan Leu (MDL)
  • Malagasy Ariary (MGA)
  • Macedonian Denar (MKD)
  • Burmese Kyat (MMK)
  • Mongolian Tögrög (MNT)
  • Macanese Pataca (MOP)
  • Mauritian Rupee (MUR)
  • Maldivian Rufiyaa (MVR)
  • Malawian Kwacha (MWK)
  • Mexican Peso (MXN)
  • Malaysian Ringgit (MYR)
  • Mozambican Metical (MZN)
  • Namibian Dollar (NAD)
  • Nigerian Naira (NGN)
  • Nicaraguan Córdoba (NIO)
  • Norwegian Krone (NOK)
  • Nepalese Rupee (NPR)
  • New Zealand Dollar (NZD)
  • Omani Rial (OMR)
  • Panamanian Balboa (PAB)
  • Peruvian Sol (PEN)
  • Papua New Guinean Kina (PGK)
  • Philippine Peso (PHP)
  • Pakistani Rupee (PKR)
  • Polish Złoty (PLN)
  • Paraguayan Guaraní (PYG)
  • Qatari Riyal (QAR)
  • Romanian Leu (RON)
  • Serbian Dinar (RSD)
  • Russian Ruble (RUB)
  • Rwandan Franc (RWF)
  • Saudi Riyal (SAR)
  • Solomon Islands Dollar (SBD)
  • Seychellois Rupee (SCR)
  • Sudanese Pound (SDG)
  • Swedish Krona (SEK)
  • Singapore Dollar (SGD)
  • Saint Helena Pound (SHP)
  • Sierra Leonean Leone (SLL)
  • Somali Shilling (SOS)
  • Surinamese Dollar (SRD)
  • São Tomé and Príncipe Dobra (STD)
  • Syrian Pound (SYP)
  • Swazi Lilangeni (SZL)
  • Thai Baht (THB)
  • Tajikistani Somoni (TJS)
  • Turkmenistani Manat (TMT)
  • Tunisian Dinar (TND)
  • Tongan Paʻanga (TOP)
  • Turkish Lira (TRY)
  • Trinidad and Tobago Dollar (TTD)
  • New Taiwan Dollar (TWD)
  • Tanzanian Shilling (TZS)
  • Ukrainian Hryvnia (UAH)
  • Ugandan Shilling (UGX)
  • United States Dollar (USD)
  • Uruguayan Peso (UYU)
  • Uzbekistani Som (UZS)
  • Vietnamese Đồng (VND)
  • Vanuatu Vatu (VUV)
  • Samoan Tālā (WST)
  • Central African CFA Franc (XAF)
  • East Caribbean Dollar (XCD)
  • West African CFA franc (XOF)
  • CFP Franc (XPF)
  • Yemeni Rial (YER)
  • South African Rand (ZAR)
  • Zambian Kwacha (ZMW)
  • Zimbabwean Dollar (ZWL)

$0.00

+ applicable taxes

Proposal turnaround typically 24–48 hours

Note: Estimate is indicative only. Final pricing is subject to scope finalization after discovery call.

REFERENCE CASELETS

Reference

Real-world examples of survey work in the diabetes care device space.

CASELET 1

CGM adoption barriers & segment friction mapping (India)

CASELET 2

Blood glucose monitor brand messaging & positioning audit (South Asia)

CGM adoption barriers & segment friction mapping (India)

OBJECTIVE

A specialty medical device distributor needed to identify why Type 2 insulin-dependent patients stalled at prescription-to-purchase, and how device cost sensitivity , caregiver influence , and physician recommendation weight shaped first-device selection across metro and Tier 2 markets.

WHAT WE DID

Ran a structured quant survey across 420 respondents in 6 cities, capturing device shortlisting triggers , out-of-pocket threshold by household income band , pharmacy vs. clinic purchase channel split , and the role of peer referral vs. endocrinologist recommendation at each decision stage.

DELIVERED

A segment friction map by patient archetype, a ranked barrier list at each purchase stage, a channel preference corridor by city tier, and a caregiver influence framework isolating where third-party voices override patient intent.
Talk to Survey Consultant
CASELET 1

CGM adoption barriers & segment friction mapping (India)

CASELET 2

Blood glucose monitor brand messaging & positioning audit (South Asia)

CGM adoption barriers & segment friction mapping (India)

OBJECTIVE

A specialty medical device distributor needed to identify why Type 2 insulin-dependent patients stalled at prescription-to-purchase, and how device cost sensitivity , caregiver influence , and physician recommendation weight shaped first-device selection across metro and Tier 2 markets.

WHAT WE DID

Ran a structured quant survey across 420 respondents in 6 cities, capturing device shortlisting triggers , out-of-pocket threshold by household income band , pharmacy vs. clinic purchase channel split , and the role of peer referral vs. endocrinologist recommendation at each decision stage.

DELIVERED

A segment friction map by patient archetype, a ranked barrier list at each purchase stage, a channel preference corridor by city tier, and a caregiver influence framework isolating where third-party voices override patient intent.

FREQUENTLY ASKED QUESTIONS

Common Questions

Answers to frequently asked questions about this survey mandate.

What decisions will this survey enable?

Who is the buyer vs who are the respondents?

Can we see differences between CGM users, BGM users and insulin pump users?

How will you measure device brand preference beyond simple ratings?

Will the survey map the full diabetes device adoption journey and drop-offs?

Can this survey inform product and pricing strategy?

How will findings improve our brand retention and commercial messaging?

Still have questions?

Schedule a discovery call to discuss your specific needs and get a custom quote.

Book a Discovery Call